The Genetic Risk of Kidney Disease in Type 2 Diabetes

Medical Clinics of North America

Volumn 97, Issue 1, 2013, Pages 91-107

  Pezzolesi, Marcus G ^a,b   Krolewski, Andrzej S ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Diabetic nephropathy; Genetic risk; Kidney disease; Type 2 diabetes

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CREATININE; PHOSPHOLIPASE C; TRANSFORMING GROWTH FACTOR BETA;

AFRICAN AMERICAN; CHROMOSOME 3Q; CHROMOSOME 7P; CHROMOSOME 9; CODON; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; FOCAL GLOMERULOSCLEROSIS; GENE FREQUENCY; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GLOMERULUS FILTRATION RATE; HERITABILITY; HUMAN; INHERITANCE; INTRON; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONSENSE MUTATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEINURIA; REVIEW; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FAMILY; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MULTIFACTORIAL INHERITANCE; PEDIGREE;

EID: 84871760121     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.10.005     Document Type: Review

References (53)

1. Parving H.H., Mauer M., Ritz E. Diabetic nephropathy. Brenner and rector's the kidney 2004, 1777-1818. Elsevier, Philadelphia. B.M. Brenner (Ed.).
2. Krolewski A.S., Warram J.H. Clinical features and epidemiology of diabetic nephropathy. Textbook of diabetes 1997, vol. 2:53.1-53.13. Blackwell Scientific Publications, Oxford (United Kingdom).
3. Jones C.A., Krolewski A.S., Rogus J., et al. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?. Kidney Int 2005, 67:1684-1691.
4. Pettitt D.J., Saad M.F., Bennett P.H., et al. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990, 33:438-443.
5. Freedman B.I., Tuttle A.B., Spray B.J. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995, 25:710-713.
6. Faronato P.P., Maioli M., Tonolo G., et al. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. Diabetologia 1997, 40:816-823.
7. Canani L.H., Gerchman F., Gross J.L. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes 1999, 48:909-913.
8. Gruden G., Cavallo-Perin P., Olivetti C., et al. Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy. Diabetologia 1995, 38:1218-1222.
9. Fogarty D.G., Rich S.S., Hanna L., et al. Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. Kidney Int 2000, 57:250-257.
10. Forsblom C.M., Kanninen T., Lehtovirta M., et al. Heritability of albumin excretion rate in families of patients with Type II diabetes. Diabetologia 1999, 42:1359-1366.
11. Krolewski A.S., Poznik G.D., Placha G., et al. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 2006, 69:129-136.
12. Langefeld C.D., Beck S.R., Bowden D.W., et al. Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis 2004, 43:796-800.
13. Placha G., Canani L.H., Warram J.H., et al. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis 2005, 12:155-169.
14. Fogarty D.G., Hanna L.S., Wantman M., et al. Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes 2000, 49:1057-1063.
15. Imperatore G., Hanson R.L., Pettitt D.J., et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 1998, 47:821-830.
16. Vardarli I., Baier L.J., Hanson R.L., et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 2002, 62:2176-2183.
17. Bowden D.W., Colicigno C.J., Langefeld C.D., et al. A genome scan for diabetic nephropathy in African Americans. Kidney Int 2004, 66:1517-1526.
18. Puppala S., Arya R., Thameem F., et al. Genotype by diabetes interaction effects on the detection of linkage of glomerular filtration rate to a region on chromosome 2q in Mexican Americans. Diabetes 2007, 56:2818-2828.
19. Chen G., Adeyemo A.A., Zhou J., et al. A genome-wide search for linkage to renal function phenotypes in West Africans with type 2 diabetes. Am J Kidney Dis 2007, 49:394-400.
20. Iyengar S.K., Abboud H.E., Goddard K.A., et al. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes 2007, 56:1577-1585.
21. Freedman B.I., Bowden D.W., Rich S.S., et al. Genome-wide linkage scans for renal function and albuminuria in Type 2 diabetes mellitus: the Diabetes Heart Study. Diabet Med 2008, 25:268-276.
22. Igo R.P., Iyengar S.K., Nicholas S.B., et al. Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. Am J Nephrol 2011, 33:381-389.
23. Schelling J.R., Abboud H.E., Nicholas S.B., et al. Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes 2008, 57:235-243.
24. Janssen B., Hohenadel D., Brinkkoetter P., et al. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 2005, 54:2320-2327.
25. Freedman B.I., Hicks P.J., Sale M.M., et al. A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrol Dial Transplant 2007, 22:1131-1135.
26. Osterholm A.M., He B., Pitkaniemi J., et al. Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney Int 2007, 71:140-145.
27. Moczulski D.K., Rogus J.J., Antonellis A., et al. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 1998, 47:1164-1169.
28. He B., Osterholm A.M., Hoverfalt A., et al. Association of genetic variants at 3q22 with nephropathy in patients with type 1 diabetes mellitus. Am J Hum Genet 2009, 84:5-13.
29. Singh N., Nainani N., Arora P., et al. CKD in MYH9-related disorders. Am J Kidney Dis 2009, 54:732-740.
30. Arrondel C., Vodovar N., Knebelmann B., et al. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol 2002, 13:65-74.
31. Kopp J.B., Smith M.W., Nelson G.W., et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008, 40:1175-1184.
32. Kao W.H., Klag M.J., Meoni L.A., et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008, 40:1185-1192.
33. Freedman B.I., Hicks P.J., Bostrom M.A., et al. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant 2009, 24:3366-3371.
34. Cooke J.N., Bostrom M.A., Hicks P.J., et al. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans. Nephrol Dial Transplant 2012, 27:1505-1511.
35. McKnight A.J., Duffy S., Fogarty D.G., et al. Association of MYH9/APOL1 with chronic kidney disease in a UK population. Nephrol Dial Transplant 2012, 27:3660.
36. Pearson T.A., Manolio T.A. How to interpret a genome-wide association study. JAMA 2008, 299:1335-1344.
37. McDonough C.W., Palmer N.D., Hicks P.J., et al. A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int 2011, 79:563-572.
38. Hanson R.L., Craig D.W., Millis M.P., et al. Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 2007, 56:975-983.
39. Shimazaki A., Kawamura Y., Kanazawa A., et al. Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 2005, 54:1171-1178.
40. Shimazaki A., Tanaka Y., Shinosaki T., et al. ELMO1 increases expression of extracellular matrix proteins and inhibits cell adhesion to ECMs. Kidney Int 2006, 70:1769-1776.
41. Hanson R.L., Millis M.P., Young N.J., et al. ELMO1 variants and susceptibility to diabetic nephropathy in American Indians. Mol Genet Metab 2010, 101:383-390.
42. Pezzolesi M.G., Katavetin P., Kure M., et al. Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy. Diabetes 2009, 58:2698-2702.
43. Leak T.S., Perlegas P.S., Smith S.G., et al. Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans. Ann Hum Genet 2009, 73:152-159.
44. Millis M.P., Bowen D., Kingsley C., et al. Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes. Diabetes 2007, 56:3027-3032.
45. Manolio T.A., Collins F.S., Cox N.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
46. Kaplan J.M., Kim S.H., North K.N., et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000, 24:251-256.
47. Kestila M., Lenkkeri U., Mannikko M., et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998, 1:575-582.
48. Boute N., Gribouval O., Roselli S., et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000, 24:349-354.
49. Hinkes B., Wiggins R.C., Gbadegesin R., et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 2006, 38:1397-1405.
50. Winn M.P., Conlon P.J., Lynn K.L., et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005, 308:1801-1804.
51. Kahn C.R., Vicent D., Doria A. Genetics of non-insulin-dependent (type-II) diabetes mellitus. Annu Rev Med 1996, 47:509-531.
52. Pezzolesi MG, Jeong J, Smiles AM, et al. Identification of rare genetic variants that contribute to diabetic nephropathy in type 2 diabetes through family-based targeted exome sequencing [abstract]. Presented at the 62nd Annual Meeting of the American Society of Human Genetics. San Francisco, November 7, 2012.
53. Veit G., Kobbe B., Keene D.R., et al. Collagen XXVIII, a novel von Willebrand factor A domain-containing protein with many imperfections in the collagenous domain. J Biol Chem 2006, 281:3494-3504.